PFBT
BHVN

Parkside Financial Bank & Trust’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Parkside Financial Bank & Trust’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-186
Closed -$16K – 1749
2020
Q4 		$16K Sell
186
-64
-26% -$5.42K 0.01% 787
2020
Q3 		$16K Buy
250
+33
+15% +$2.16K 0.01% 724
2020
Q2 		$16K Buy
+217
New +$11.5K 0.01% 717

Other funds holding BHVN

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Parkside Financial Bank & Trust's BHVN Position: Q1 2021 in Review

Parkside Financial Bank & Trust sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q1 2021, closing a stake of 186 shares — an estimated $16K sold.

Parkside Financial Bank & Trust first reported a position in BHVN in Q2 2020 and held it in 3 quarters. The position peaked at $16K in Q4 2020. 224 funds tracked by Wall St. Rank hold BHVN as of Q1 2021.

  • Parkside Financial Bank & Trust reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q1 2021 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 186 Biohaven Pharmaceutical Holding Company Ltd. shares in Q1 2021, an estimated $16K.
  • Parkside Financial Bank & Trust first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2020 and held it in 3 quarters.
  • Parkside Financial Bank & Trust's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $16K in Q4 2020.
  • 224 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q1 2021.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2021, filed 10 May 2021.